Coronavirus Update: BARDA Funding Rises To $955m As Moderna Expands Phase III Trial
30,000 Recruitment Target For All US-Sponsored Trials
Moderna has updated its protocol, expanding its recruitment target to 30,000 and aiming for more ethnically diverse and at-risk groups to be included.
